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A Comparison of Danish and Canadian 
Consumer Medication Information 
Helen MONKMANa,1 Christian NØHRb, and Andre W. KUSHNIRUK a 
a
 School of Health Information Science, University of Victoria 
b Department of Planning, Aalborg University 
Abstract. Many people around the world use prescription medications. Consumers 
often require information about their medications to support taking them safely 
and effectively. One source of such information is Consumer Medication 
Information (CMI). Canadians typically receive printed CMI when a new 
prescription is filled whereas Danes have the online resource min.medicin.dk.  
This study compared the content and design of Danish and Canadian CMI.  Danish 
CMI satisfied seven of the 11 content utility criteria (developed in previous work) 
identified as supporting the safe and effective medication use. However, Danish 
CMI provided a more information about how frequently possible side effects occur 
and multimedia (e.g., images, videos) directions for some medications. This study 
examined some of the similarities and differences between how Canadians and 
Danes are informed about medications. However, further research is required to 
determine what content and methods of delivery are most beneficial in supporting 
safe and effective medication use.   
Keywords. Consumer Medication Information, Patient Education, Patient Leaflets, 
Content Utility, Information Design, Consumer Health Informatics 
Introduction 
Many people around the world take prescription medicines, whether it be for a short 
duration (e.g., antibiotics) or an ongoing basis. Taking a prescription medication has 
benefits and risks (e.g., side effects, overdoses). Denmark and Canada both have 
publicly funded healthcare systems. However, these countries have different 
approaches for informing their citizens about prescription medications.  
Consumers having access to medication information is important for the safe and 
effective use of prescription medications. Canadian consumers have multiple resources 
for medication information. One of the most common resources is what the authors 
refer to as Consumer Medication Information (CMI). When a Canadian fills a new 
prescription (i.e., one never used before, not a refill) a pharmacist will typically 
verbally discuss important aspects of safe and effective use of the prescription and 
provide the consumer with CMI printed on paper.  
CMI is not reviewed by Health Canada because it is considered “part of the 
practice of pharmacy, which is the responsibility of provincial authorities” [1]. 
However, because CMI is not regulated, the information (or the lack thereof) a 
consumer receives depends on where a new prescription is filled. Monkman and 
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Kushniruk [2] found that CMI for the same medication was inconsistent between 
pharmacies. Further, CMI is not always consistent with regulated medication 
information referred to as product monographs which offers comprehensive 
information about prescription medications [1]. To resolve any discrepancies, product 
monographs are now available online [3]. However, how popular such sites are with 
Canadians or whether they even are aware this resource is available (as they are not 
referenced in CMI) remains unknown. 
Although Denmark also uses CMI to inform its citizens about the safe and 
effective use of medications, the method of distributing CMI is quite different than the 
Canadian protocol. Specifically, Danes are informed by the pharmacist or pharmacist 
assistant when the drug is picked up at the pharmacy, but are not offered information in 
print with new prescriptions. Instead, Danes are encouraged to visit the national 
website min.medicin.dk which offers medication information developed for patients. 
This site is hyperlinked to two other websites 1) pro.medicin.dk, targeted towards 
healthcare professionals, and 2) indlaegssedler.dk, offering paper package inserts 
online, as well as additional information (e.g., videos on how to use the medication). In 
addition to CMI, min.medicin.dk offers several other tools. Danes can enter different 
characteristics of a medication (i.e., type, embossing, letters and numbers, shape, 
colour, and whether it is grooved) to identify medications. The site also provides 
information about diseases as well as instructional movies and slideshows. As with 
Canadian CMI, information on min.medicin.dk may differ from the paper package 
inserts because the website may incorporate information from additional sources. 
This study will compare the content utility (i.e., what information is conveyed) and 
design (i.e., how the information is displayed) of CMI from Canada and Denmark. 
1. Methods 
Monkman and Kushniruk previously developed and used a framework to evaluate the 
readability and content utility of CMI from different pharmacies for the same 
medication [2], as well different medications from the same pharmacy [4]. Drawing 
from resources for safe and effective medication (primarily the Consumer Information 
Rating Form [5]), 11 content utility criteria were used in the framework: Benefits, 
Contraindications, Directions, Missed Dose, Precautions, Adverse Effects, Allergic 
Reactions, Drug Interactions, Overdose, Storage and General Information [2, 4]. Given 
that translation may confound measures of readability (i.e., word count, readability 
score, and reading time), only content utility criteria from this framework were 
compared between Canadian and Danish CMI. It should be noted that neither previous 
evaluation identified a single medication that satisfied all the content utility criteria [2, 
4]. Thus, these categories an idealized framework for what should be included in CMI 
to inform safe and effective medication use. The 11 content utility criteria from this 
framework were used to assess the information in Danish CMI. 
Min.medicin.dk provides a standardized format for its CMI. The landing page 
includes the name of the medication in large font as well as a brief sentence below to 
describe the medications purpose and why it works (e.g., “Avamys is a remedy for 
hayfever. Corticosteroid”). The conditions a medication is used to treat and the dosage 
forms (e.g., nasal spray, ointment, intravenous, inhaler, tablet) are also listed and are 
hyperlinked to descriptions of the conditions. Generic names can be searched, but only 
brand name medications are shown for CMI. Every medication has the same series of 
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standard collapsible content categories as well as some additional categories only if 
relevant to the medication (e.g., “Traffic: Caution is advised when operating 
machinery”). Standard categories (i.e., shown for every medication) from 
minmedicin.dk were compared with Monkman and Kushniruk’s content utility Criteria 
[2, 4] to examine the topics the countries communicate in their CMI. Additionally, 
design differences between Danish and Canadian CMI were examined. 
The authors attempted to use the same 10 medications from a previous study [4]. 
However, Zatidor, Loprox, Parnate were not listed on the min.medicin.dk, so they were 
substituted with other medications of the same route to maintain two medications per 
route (i.e., nasal sprays, inhalers, eye drops, creams, and tablets). Additionally, an 
injected medication, was added to this investigation. Thus, this study examined CMI 
from min.medicin.dk for 11 medications (i.e., Avamys, Nasonex, Onbrez, Asmanex, 
Acular, Sandoz-Timolol, Betnovate, Aldara, Doxycycline, Sibelium, and Xomolix). 
2. Results 
2.1. Content Utility 
Seven of the 11 content utility [2, 4] criteria were satisfied by the standard categories of 
the Danish CMI examined (see Table 1). Of the shared categories (i.e., those in both 
Danish and Canadian CMI), Adverse Effects, Contraindications, and Directions 
demonstrated that despite addressing similar topics, content was communicated to 
consumers differently and these differences will be discussed in more detail.  
Table 1. Similarities Between Monkman and Kushniruk’s [2, 4] Content Utility Criteria and the Standard 
min.medicin.dk Content Categories 
Content Utility Criteria 
Min.medicin.dk  
Standard Content Categories 
Contraindications  
Who should not use the medication 
Do Not Use 
Who should not use the medication 
Pregnancy 
If a medication is suitable for use during pregnancy 
Breast Feeding 
If a medication is suitable for use while breastfeeding 
Adverse Effects 
Possible side effects and what to do 
about side effects 
Adverse Effects 
Possible side effects and how frequently they occur organized in 
tabular format. Other, more rare, side effects are listed. A 
hyperlink offers additional general information on side effects 
and how to respond if they occur. 
Drug Interactions 
Medications that may be problematic 
to use in conjunction  
Taking Other Medications 
Medications that may be problematic to use in conjunction 
Precautions 
Precautions that need to be taken while 
using the medication 
Special Warnings 
People who should use the medication with caution, symptoms 
that warrant immediate attention from a healthcare provider, or 
general warnings. 
Directions 
Specific directions about how to take 
the medication 
Instructions (if applicable) 
Slide show or video of how to administer the medication 
Benefits 
The benefits of taking the medication 
General information  
(e.g., description of medication) 
Application 
What the medication is used to treat and any requirements 
necessary for it to be effective. 
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Differences were observed between how Canadian and Danish CMI communicated 
adverse effects. In a previous study of CMI from three different Canadian pharmacies, 
side effects were classified as possible, serious, and rare but serious depending on the 
pharmacy source [2]. However, the CMI in Monkman and Kushniruk’s previous 
investigations [2, 4] merely listed the potential side effects but no indication of the 
probability one would experience a side effect if taking the medication was conveyed. 
In contrast, the Danish CMI reported side effects in more detail and in a tabular format. 
All the possible side effects in the Danish CMI were qualified in terms of frequency 
using words (e.g., very common, general, uncommon, rare) with corresponding 
proportions (e.g., no more than 1 out of 100 people).  
How contraindications were categorized varied between Canadian and Danish 
CMI. Specifically, Denmark used Pregnancy and Breastfeeding as independent 
categories in their CMI and identified whether it was safe to use the medication under 
these circumstances. In contrast, Canadian CMI describes whether a medication may be 
used under supervision (i.e., a precaution) or not (i.e., a contraindication) while a 
woman is pregnant or breastfeeding. Despite being comparable to contraindications in 
Table 1, pregnancy and/or breastfeeding may be discussed as precautions or may not be 
mentioned at all in Canadian CMI if there is no cause for concern. 
The four content utility categories not present in Danish CMI were Missed Dose, 
Allergic Reaction, Overdose, and Storage. Despite these shortcomings, Danish CMI 
contained nine additional standard content categories (see Table 2). However, not all 
Canadian CMI previously studied satisfied these criteria either [2, 4]. Further, despite 
not explicitly mentioning Allergic Reactions, the active ingredients and the excipients 
were listed in Danish CMI and could be used to detect potential allergens.  
Table 2. Additional Standard Content Categories from minmedicin.dk Not Included in Monkman and 
Kushniruk’s [2, 4] Content Utility Criteria 
Additional Min.medicin.dk Standard Content Categories 
Active Substances 
The ingredients that make the medication effective. 
Dosage 
Common doses for different groups (e.g., adults and children, male or female) as applicable, notes for 
use (e.g., shake the container before using, use consistently for full effect) 
Blood Donor 
If donating blood should be avoided while taking this medication 
Effect 
How the medication works in the body 
Pharmaceutical Forms 
The different formulations of the medication available 
Excipients 
Inactive substances that serve as the medium 
Company 
The pharmaceutical manufacturer 
Packages, Prices, Subsidies, and Extradition 
If the medication is subsidized by the healthcare system, if a prescription is necessary to receive it, the 
dosage forms and strengths, packages available, and respective price for the different producers of the 
drug. 
Image Identification 
Photographs of the medication   
Generally, Danish CMI provided more detailed information, some of which may 
be important for safe and effective medication use. For example, knowing what the 
medication looks like might be important, especially for people who get multiple drugs 
or those who have their daily mediations combined into blister packs. Other topics may 
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be for people who want a deeper understanding of the medication such as how the 
medication works in the body. Some information suited other purposes such as whether 
you could give blood while taking this medication. However, some of the topics not 
important for medication safety but more for general information (e.g., packaging, 
company, cost). Consumers may find cost information very valuable. 
2.2. Design 
Canadian CMI is provided solely in text, whereas Danish CMI made use of multimedia 
to support the information. For example, pictures of the medication were used in the 
Image Identification category. Slide shows were also used to demonstrate the steps or 
procedure of how to apply both nasal sprays and eye drops in the Danish CMI. 
Moreover, videos showed how inhalers should be used.  There are inherent limitations 
to Canadian CMI, as it is primarily printed on paper. Only one of the pharmacies in the 
authors’ previous work on Canadian CMI was offered online [2]. In contrast to paper, 
min.medicin.dk provides the user with an overview of the information contained on the 
page without being overwhelming and may facilitate finding specific information. 
Specifically, the content categories were collapsed on min.medicin.dk  landing pages 
allowing the different information topics to be visible simultaneously. Thus, rather than 
a dense wall of text, users were only shown headings with ample negative space. This 
format should expedite information seeking behavior and allow users to find answers to 
their questions more quickly than having to parse all the text available on a medication. 
Monkman and Kushniruk [2] reported that despite the one Canadian CMI examined 
online being the most comprehensive (and lengthy), it was unfortunately designed as a 
single long page without collapsible categories and therefore failing to facilitate 
information seeking. 
3. Discussion  
As previously noted, the method of providing consumers with CMI between countries 
is different and appeared to have implications on both the content and design. With 
respect to content, despite providing mostly similar information, how the information 
was categorized was slightly different for some topics between the two countries. 
Generally, the Danish CMI contained more topics, but some had limited relevancy to 
the safe and effective use of medications. 
Many of the design differences between Danish and Canadian CMI may result 
from the different dispensing methods (i.e., hardcopy vs. digital). Danish CMI often 
complemented text with multimedia where possible (e.g., pictures of the medication, 
videos of how to use the medication), whereas Canadian CMI is strictly limited to text. 
Further, Monkman and Kushniruk [4] described the missed opportunity of Canadian 
CMI in avoiding describing the procedural steps of using inhalers and instead referred 
consumers to the paper package inserts. In contrast, Danish CMI not only collocates 
instructions, but it also uses videos to demonstrate the steps, which may be clearer and 
potentially more memorable than text.   
Another advantage to min.medicin.dk is that, to some extent, Danes are provided 
with a “single source of truth” with respect to medication information. Although, there 
may be some discrepancy between types of medication information (e.g., CMI vs. 
paper package inserts) in Denmark, it is not likely to be as variable as in Canada. The 
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CMI Canadians receive is dependent on the pharmacy used to fill a prescription [1]. 
Therefore, Canadians are getting more, less, or simply different information depending 
on the pharmacy they use to fill their prescriptions. 
Providing eHealth solutions (e.g., online CMI) may unintentionally exacerbate the 
digital divide or difference between People Like Us (PLUs) and the Disadvantages, 
Disconnected, and Disengaged (DDDs), whereas paper CMI is equally accessible by 
everyone [6]. That is, Danish CMI is only available online and therefore users a) must 
seek it out and b) navigate min.medicin.dk to find information. However, the user 
controls the amount of visible information on min.medicin.dk through expandable 
categories. Users are significantly faster, more accurate, remember better, and prefer 
websites that have concise content that is easy to scan [7]. Danish CMI also 
complements text with images, video, and narration which may support understanding. 
In contrast, Canadians are provided paper copies of CMI with every new prescription 
and might be more inclined to read it than if they had to seek it out. No navigation is 
required with printed CMI. However, in this format all information must be displayed 
simultaneously, which has the potential to overwhelm users. Unfortunately, the only 
example of Canadian online CMI studied from our previous work failed to capitalize 
on the digital medium (i.e., it was simply a long page of text) [2] and was likely more 
difficult to use, read, and understand as a result. Both methods of delivery have their 
respective advantages and disadvantages. However, the design of Danish CMI 
appeared to be superior on many levels. A limitation of this study is that the actual 
written content could (e.g., number of words, readability score) could not be evaluated. 
Further research is required to determine which delivery method is more accessible and 
understandable from a user’s perspective in terms of delivery, content, and design.  
This study identified some similarities and differences between how Canadians 
and Danes are informed about medications. International comparisons may prove 
useful in leveraging the advantages of different approaches to designing and dispensing 
CMI to improve future CMI.  However, further research is required to determine what 
content, design, and methods of delivery are most beneficial supporting safe and 
effective medication use. The first author is working towards this goal by examining 
Canadian consumers’ opinions, preferences, and memorability of CMI. Additionally, 
how and when consumers seek out CMI as well as how these resources are used  and 
understood in naturalistic settings also warrants investigation. 
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